The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...
Cat Price, 20, sits outside her Colorado Springs home on Thursday, Oct. 23, 2025. She was diagnosed with schizophrenia at 18, two years later with the help of medication, therapy and support from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results